The Role of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Hodgkin Lymphoma

Por Holmberg, Leona, Maloney, David G.
Publicado em 2011

Rituximab Resistance

Por Rezvani, Andrew R., Maloney, David G.
Publicado em 2011

Stem cell transplantation for indolent lymphoma and chronic lymphocytic leukemia

Por Gribben, John G, Hosing, Chitra, Maloney, David G.
Publicado em 2011

Early recovery of CD4 T cell receptor diversity after “lymphoablative” conditioning and autologous CD34 cell transplantation

Por Storek, Jan, Zhao, Zhao, Liu, Yiping, Nash, Richard, McSweeney, Peter, Maloney, David G.
Publicado em 2008

Rituximab blocks binding of radiolabeled anti-CD20 antibodies (Ab) but not radiolabeled anti-CD45 Ab

Por Gopal, Ajay K., Press, Oliver W., Wilbur, Shani M., Maloney, David G., Pagel, John M.
Publicado em 2008

Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia

Por Sorror, Mohamed L., Storer, Barry E., Maloney, David G., Sandmaier, Brenda M., Martin, Paul J., Storb, Rainer
Publicado em 2008

The Impact of Donor Type and ABO Incompatibility on Transfusion Requirements after Nonmyeloablative Hematopoietic Cell Transplantation (HCT)

Por Wang, Zejing, Sorror, Mohamed L., Leisenring, Wendy, Schoch, Gary, Maloney, David G., Sandmaier, Brenda M., Storb, Rainer
Publicado em 2010

Identification of MAGE-C1 (CT-7) epitopes for T-cell therapy of multiple myeloma

Por Anderson, Larry D., Cook, Danielle R., Yamamoto, Tori N., Berger, Carolina, Maloney, David G., Riddell, Stanley R.
Publicado em 2011

Allogeneic Hematopoietic Cell Transplantation in Patients with Myelodysplastic Syndrome and Concurrent Lymphoid Malignancy

Por Zimmerman, Zachary, Scott, Bart L., Gopal, Ajay K., Sandmaier, Brenda M., Maloney, David G., Deeg, H. Joachim
Publicado em 2011

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

Por Sorror, Mohamed L., Maris, Michael B., Storb, Rainer, Baron, Frederic, Sandmaier, Brenda M., Maloney, David G., Storer, Barry
Publicado em 2005

Cytopenias after day 28 in allogeneic hematopoietic cell transplantation: impact of recipient/donor factors, transplant conditions and myelotoxic drugs

Por Nakamae, Hirohisa, Storer, Barry, Sandmaier, Brenda M., Maloney, David G., Davis, Chris, Corey, Lawrence, Storb, Rainer, Boeckh, Michael
Publicado em 2011

Chimeric antigen receptor-modified T cells derived from defined CD8(+) and CD4(+) subsets confer superior antitumor reactivity in vivo

Por Sommermeyer, Daniel, Hudecek, Michael, Kosasih, Paula L., Gogishvili, Tea, Maloney, David G., Turtle, Cameron J., Riddell, Stanley R.
Publicado no Leukemia (2015)

Allogeneic Hematopoietic Cell Transplant for Patients with End Stage Renal Disease Requiring Dialysis – a Single Institution Experience

Por Shadman, Mazyar, Hingorani, Sangeeta, Lanum, Scott A., Pagel, John M., Storb, Rainer, Maloney, David G., Sandmaier, Brenda M.
Publicado no Leuk Lymphoma (2016)

What is the role for donor NK cells after nonmyeloablative conditioning?

Por Baron, Frédèric, Petersdorf, Effie W., Gooley, Ted, Sandmaier, Brenda M., Malkki, Mari, Chauncey, Thomas R., Maloney, David G., Storb, Rainer
Publicado em 2009

Impact of donor age on outcome after allogeneic hematopoietic cell transplantation

Por Rezvani, Andrew R., Storer, Barry E., Guthrie, Katherine A., Schoch, H. Gary, Maloney, David G., Sandmaier, Brenda M., Storb, Rainer
Publicado no Biol Blood Marrow Transplant (2014)

Comparable Outcomes after Nonmyeloablative Hematopoietic Cell Transplantation with Unrelated and Related Donors

Por Mielcarek, Marco, Storer, Barry E., Sandmaier, Brenda M., Sorror, Mohamed L., Maloney, David G., Petersdorf, Effie, Martin, Paul J., Storb, Rainer
Publicado em 2007

Allogeneic Hematopoietic Cell Transplantation Following Minimal Intensity Conditioning: Predicting Acute Graft-vs.-Host Disease and Graft-vs.-Tumor Effects

Por Storb, Rainer, Gyurkocza, Boglarka, Storer, Barry E., Maloney, David G., Sorror, Mohamed L., Mielcarek, Marco, Martin, Paul J., Sandmaier, Brenda M.
Publicado em 2013

Adoptive Therapy with Chimeric Antigen Receptor Modified T Cells of Defined Subset Composition

Por Riddell, Stanley R., Sommermeyer, Daniel, Berger, Carolina, Liu, Lingfeng (Steven), Balakrishnan, Ashwini, Salter, Alex, Hudecek, Michael, Maloney, David G., Turtle, Cameron J.
Publicado em 2014

Radioimmunotherapy Consolidation using (131)I-Tositumomab for Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in First Remission

Por Shadman, Mazyar, Gopal, Ajay K., Kammerer, Britt, Becker, Pamela S., Maloney, David G., Pender, Barbara, Shustov, Andrei R., Press, Oliver W., Pagel, John M.
Publicado no Leuk Lymphoma (2015)

Effect of Conditioning Regimen Intensity on CMV Infection in Allogeneic Hematopoietic Cell Transplantation

Por Nakamae, Hirohisa, Kirby, Katharine A., Sandmaier, Brenda M., Norasetthada, Lalita, Maloney, David G., Maris, Michael B., Davis, Chris, Corey, Lawrence, Storb, Rainer, Boeckh, Michael
Publicado em 2009